What Causes Mast Cell Activation Syndrome
Roelofzen JH, Aben KK, Oldenhof UT, Coenraads PJ, Alkemade HA, van de Kerkhof PC,
This is essential reading for anyone involved in or interested in the field of peptides
The first GLP-1 analog was approved for the treatment of type 2 diabetes in 2005 Trusted Source PubMed Central Go to source
The concurrent engagement of all three receptors is hypothesised to produce complementary metabolic effects in pre-clinical models: GLP-1R activation is associated with glucose regulation and appetite modulation, GIPR activation with potentiation of GLP-1mediated responses, and GcgR activation with energy expenditure and hepatic lipid metabolism in laboratory settings
They published a paper in iScience describing the mechanism